202 related articles for article (PubMed ID: 22381424)
21. Platelet inhibitors: what are the data in women?
Tempelhof MW; Newby LK
Cardiol Rev; 2008; 16(1):23-9. PubMed ID: 18091399
[TBL] [Abstract][Full Text] [Related]
22. Scientific and therapeutic advances in antiplatelet therapy.
Bhatt DL; Topol EJ
Nat Rev Drug Discov; 2003 Jan; 2(1):15-28. PubMed ID: 12509756
[TBL] [Abstract][Full Text] [Related]
23. Impact of platelet testing on presurgical screening and implications for cardiac and noncardiac surgical procedures.
Bracey AW; Grigore AM; Nussmeier NA
Am J Cardiol; 2006 Nov; 98(10A):25N-32N. PubMed ID: 17097415
[TBL] [Abstract][Full Text] [Related]
24. Coronary atherothrombotic disease: progress in antiplatelet therapy.
Badimon L; Vilahur G
Rev Esp Cardiol; 2008 May; 61(5):501-13. PubMed ID: 18462654
[TBL] [Abstract][Full Text] [Related]
25. The P2Y12 receptor as a therapeutic target in cardiovascular disease.
Storey RF
Platelets; 2001 Jun; 12(4):197-209. PubMed ID: 11454254
[TBL] [Abstract][Full Text] [Related]
26. Bleeding risk of combined oral anticoagulant and antiplatelet therapy in cardiovascular disease.
Verheugt FW
J Cardiovasc Risk; 1996 Apr; 3(2):229-32. PubMed ID: 8836868
[TBL] [Abstract][Full Text] [Related]
27. Current concepts in antiplatelet therapy for cardiovascular disease.
Martinez A
JAAPA; 2004 Mar; 17(3):16-20, 23-4; quiz 51-2. PubMed ID: 15314880
[No Abstract] [Full Text] [Related]
28. Platelet activation in essential hypertension: implications for antiplatelet treatment.
Gkaliagkousi E; Passacquale G; Douma S; Zamboulis C; Ferro A
Am J Hypertens; 2010 Mar; 23(3):229-36. PubMed ID: 20094035
[TBL] [Abstract][Full Text] [Related]
29. Platelet function testing and implications for clinical practice.
Collet JP; Montalescot G
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):157-69. PubMed ID: 19721130
[TBL] [Abstract][Full Text] [Related]
30. Platelet inhibitor therapy for patients with cardiovascular disease: looking toward the future.
Aljaroudi WA; Halabi AR; Harrington RA
Curr Hematol Rep; 2005 Sep; 4(5):397-404. PubMed ID: 16131442
[TBL] [Abstract][Full Text] [Related]
31. Platelet inhibitors and monitoring platelet function: implications for bleeding.
Shore-Lesserson L
Hematol Oncol Clin North Am; 2007 Feb; 21(1):51-63. PubMed ID: 17258118
[TBL] [Abstract][Full Text] [Related]
32. Platelet function and response to aspirin: gender-specific features and implications for female thrombotic risk and management.
Zuern CS; Lindemann S; Gawaz M
Semin Thromb Hemost; 2009 Apr; 35(3):295-306. PubMed ID: 19452405
[TBL] [Abstract][Full Text] [Related]
33. Aspirin and clopidogrel resistance: an emerging clinical entity.
Wang TH; Bhatt DL; Topol EJ
Eur Heart J; 2006 Mar; 27(6):647-54. PubMed ID: 16364973
[TBL] [Abstract][Full Text] [Related]
34. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
[TBL] [Abstract][Full Text] [Related]
35. Developments in antiplatelet therapy for acute coronary syndromes and considerations for long-term management.
Cowley MJ; Kuritzky L
Curr Med Res Opin; 2009 Jun; 25(6):1477-90. PubMed ID: 19419337
[TBL] [Abstract][Full Text] [Related]
36. Novel antiplatelet therapy.
Gaglia MA; Manoukian SV; Waksman R
Am Heart J; 2010 Oct; 160(4):595-604. PubMed ID: 20934552
[TBL] [Abstract][Full Text] [Related]
37. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
[TBL] [Abstract][Full Text] [Related]
38. [A current problem in atherothrombotic diseases--aspirin resistance: definition, mechanisms, determination with laboratory tests and clinical implications].
Pamukçu B; Oflaz H; Nişanci Y
Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():20-6. PubMed ID: 18160363
[TBL] [Abstract][Full Text] [Related]
39. Platelet dysfunction in central obesity.
Anfossi G; Russo I; Trovati M
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):440-9. PubMed ID: 19346117
[TBL] [Abstract][Full Text] [Related]
40. Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.
Konstantopoulos K; Mousa SA
Curr Opin Investig Drugs; 2001 Aug; 2(8):1086-92. PubMed ID: 11892918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
